Drugs / DPT extract
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01489020 | Jan → Jul 2011 | allergic disease | Roxall Medicina España S.A | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DPT extract | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01489020 ↗ |
| Modality | Vaccine | “DPT depot vaccine” NCT01489020 ↗ |
| Route | Subcutaneous | “Increasing doses of subcutaneous immunotherapy in three different scales up to the maximum dose of 500 TSU (Treatment Standardized Units)” NCT01489020 ↗ |